Correlation Between Allogene Therapeutics and Tonix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Tonix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Tonix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Tonix Pharmaceuticals Holding, you can compare the effects of market volatilities on Allogene Therapeutics and Tonix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Tonix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Tonix Pharmaceuticals.

Diversification Opportunities for Allogene Therapeutics and Tonix Pharmaceuticals

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Allogene and Tonix is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Tonix Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tonix Pharmaceuticals and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Tonix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tonix Pharmaceuticals has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Tonix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Allogene Therapeutics and Tonix Pharmaceuticals

Given the investment horizon of 90 days Allogene Therapeutics is expected to generate 0.55 times more return on investment than Tonix Pharmaceuticals. However, Allogene Therapeutics is 1.8 times less risky than Tonix Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Tonix Pharmaceuticals Holding is currently generating about -0.19 per unit of risk. If you would invest  540.00  in Allogene Therapeutics on September 1, 2024 and sell it today you would lose (290.00) from holding Allogene Therapeutics or give up 53.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Allogene Therapeutics  vs.  Tonix Pharmaceuticals Holding

 Performance 
       Timeline  
Allogene Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Allogene Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Allogene Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Tonix Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Allogene Therapeutics and Tonix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allogene Therapeutics and Tonix Pharmaceuticals

The main advantage of trading using opposite Allogene Therapeutics and Tonix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Tonix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will offset losses from the drop in Tonix Pharmaceuticals' long position.
The idea behind Allogene Therapeutics and Tonix Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamental Analysis
View fundamental data based on most recent published financial statements